ISOCHECKS
  • Sign In
  • Create Account

  • Bookings
  • My Account
  • Signed in as:

  • filler@godaddy.com


  • Bookings
  • My Account
  • Sign out

  • Home
  • Services
    • Validation Services
    • Implementation
    • Accreditation Services
    • Product Development
    • Training services
  • about us
  • Further information
    • Regulation updates
    • Case Studies
    • Blog
    • Terms and Conditions
    • Privacy Policy
    • Modern Slavery Statement
  • More
    • Home
    • Services
      • Validation Services
      • Implementation
      • Accreditation Services
      • Product Development
      • Training services
    • about us
    • Further information
      • Regulation updates
      • Case Studies
      • Blog
      • Terms and Conditions
      • Privacy Policy
      • Modern Slavery Statement
ISOCHECKS

Signed in as:

filler@godaddy.com

  • Home
  • Services
    • Validation Services
    • Implementation
    • Accreditation Services
    • Product Development
    • Training services
  • about us
  • Further information
    • Regulation updates
    • Case Studies
    • Blog
    • Terms and Conditions
    • Privacy Policy
    • Modern Slavery Statement

Account


  • Bookings
  • My Account
  • Sign out


  • Sign In
  • Bookings
  • My Account

Focus on In-house tests

Conditions to consider

 When the manufacturer's validation isn't enough

A manufacturer's performance data may not fully apply when your laboratory changes how an IVD is used.

For example, you may be:

  • Using a different specimen type
  • Modifying sample preparation
  • Changing an extraction process
  • Using different instrumentation
  • Altering analytical parameters
  • Combining reagents or platforms
  • Using an assay outside its intended purpose
  • Developing your own laboratory method
  • Using an RUO reagent within a clinical workflow
  • Applying an established assay to a new clinical indication

In these situations, your laboratory needs to consider what evidence is required for your specific intended use.

Learn More

This is a content preview space you can use to get your audience interested in what you have to say so they can’t wait to learn and read more. Pull out the most interesting detail that appears on the page and write it here.

Find out more

Focus on IQC for ISO 15189

IQC ISO15189 2022 Standard 7.3.7.2

IQC ISO15189 2022 Standard 7.3.7.2

Document section highlighting internal quality control (IQC).

The structure and content of ISO 15189:2022 have been revised. 

For IQC Standards 7.3.7.2 focus is on specifications based on the intended clinical application of the examination.

 

Key Change

IQC ISO15189 2022 Standard 7.3.7.2

Medical professionals joining hands symbolizing teamwork.

The IQC section has been expanded from three subclauses to seven (a-g) where ‘a’ is defined as:

a1) The intended clinical application of the examination should be considered, as the performance specifications for the same measurand can differ in different clinical settings. 

IQC Design requirements

How to select IQC materials? To be fit for purpose!

Bubbles in a test tube filled with blue liquid.

When designing an appropriate QC strategy several risk factors need to be taken into consideration:

  1. High-risk tests with a large impact on the wrong result
  2. Tests used to support the clinician’s decision in isolation
  3. Tests acted upon immediately


How to select IQC materials? To be fit for purpose!

How to select IQC materials? To be fit for purpose!

Doctor holding a holographic human figure.

  1. Stability concerning properties of interest. 
  2. Matrix as close as possible to the examination method & as close as possible to the patient sample. 
  3. Concentration levels at/near the clinical decision limits and, when possible, covering the measurement range.

Third-party quality control materials

Manufactured  based on the intended clinical application specifications of the examination to monitor. 

They are designed to deliver an unbiased and independent assessment of performance with any instrument or method, enabling laboratories to gain accreditation and ensure optimum performance and accuracy in clinical laboratory.

Become Compliant

Embed Third party controls in clinical testing  to cover critical decision  points  to avoid testing accreditation noncompliance.

 Remember, IQC is not just about compliance; it is about managing quality effectively. Implementing correct levels of IQC in a medical laboratory is essential to ensure accurate and reliable test results.   

Find out more

Spotlight on ISO 15189 and In-House IVDR requirements

Your next steps as a medical laboratory

 ISO 15189 specifically focuses on the unique requirements of medical laboratories and the significance should not be underestimated, especially in the field of public health.  ISO 15189 was fundamentally revised at the end of 2022. It sets out more detailed requirements and emphasizes the importance of risk management even more strongly. Furthermore  Vitro Diagnostic Medical Devices regulation (IVDR) now makes concrete demands on laboratories.  A lot of medical laboratories are not fully aware of the existing and the new requirements. Lets review some of the main points:

 

In-house IVD: What are they? An IVD is  “a laboratory developed test (LDT)  that is designed, manufactured and used within a single laboratory or  within health institutions established in the Union”.   This includes any device used to examine or monitor humans, including “software or systems” connected to in vitro activity. 

 A medical laboratory can also create CE Marked devices to an LDT by:   

  • combining  products or processes that are not intended for the combination, or
  • uses a CE-IVD device outside its intended purpose, e.g., when they:
    • misuse the device (off-label use) or
    • modify commercial devices (including if they deviate from the instructions for use of conventional IVD devices).


What are Legal requirements for IVDR?

Laboratories must develop, manufacture and surveil their own Laboratory Developed Tests (largely) in conformity with the requirements of the IVDR depending on a product’s risk classification.  There are four categories (A to D) with A representing the lowest risk and D the highest. 

The use of commercially available IVD devices is preferred and laboratories can only offer their own LDTs if the devices on the market do not meet the required performance.


Your next steps as a medical laboratory?

  •  You first need to identify and  determine your product/assay's risk classification.
  • Comply with the additional requirements of Article 5 (5) of the IVDR. This in main requires a clinical validation. 
  • Expand your quality management system to include regulations of laboratory developed tests. 


Modifying an existing assay or using a commercial IVD in a different way?

 

Let us work out the evidence you need.

Tell us what you've developed, modified or implemented — and where you're currently stuck.

Get Started

Related Areas of Standard

ISO 13485: 2016

NCCLS document EP9-A2

NCCLS document EP9-A2

  

7.0 Product realisation

7.3 Design and development

7.3.2 Design and development planning

Learn more

NCCLS document EP9-A2

NCCLS document EP9-A2

NCCLS document EP9-A2

 Method Comparison and Bias Estimation Using Patient Samples 

Learn more

ISO 15189, 2022

NCCLS document EP9-A2

ISO 15189, 2022

 7.3.3 Requirements for Quality and Compliance and manufacturing process”

Learn more

Know the difference requirements between Analytical vs Clinical performance requirements

Join us and discover what we can do for you.

Analytical Performance

 

Precision
How consistently does the method produce results?

Accuracy / Trueness
How close are results to an appropriate reference or comparator?

Analytical Measurement Range
Across what range can the method provide reliable results?

Linearity
Does the method respond appropriately across the intended measuring range?

Detection Capability
Can the method reliably detect clinically relevant levels?

Analytical Specificity
Does the assay measure the intended target without significant interference?

Interference
Could endogenous or exogenous substances affect results?

Reproducibility
Does performance remain consistent across relevant operators, runs, instruments or time periods?



Clinical performance matters too

A method can perform well analytically and still require careful consideration of its clinical application.

Depending on the test, this may involve evaluation of:

  • Clinical sensitivity
  • Clinical specificity
  • Positive and negative populations
  • Clinically relevant decision points
  • Representative patient populations
  • Comparator methods
  • Clinical concordance
  • Intended clinical application



Challenges for Medical devices in clinical practice

Medical devices Regulations

Medical devices Regulations

Medical devices Regulations

 New In-Vitro Diagnostics Regulation(IVDR)  and ISO 15189, 2022 introduces new compliance challenges for manufacturers and testing laboratories using in-house devices 

Laboratory developed test

Medical devices Regulations

Medical devices Regulations

IVDR now makes concrete demands on laboratories using any laboratory developed test.  A lot of medical laboratories are not fully aware of the existing and the new requirements

Intended use deviation

Intended use deviation

Intended use deviation

With a rapidly changing world of therapeutics a lot of devices do not have 

 clinical performance studies or clinical testing to  correlate with the products stated 'intended use' provided with the IVD technical documentation    

Implementation delays

Intended use deviation

Intended use deviation

Verification process delays with Clinical laboratories trying to achieve ISO accreditation leaving new and better devices out of clinical use.

Pathology organizations adopting a multi-site hub and spoke model introduces new implementation challenges for laboratory management 

Accreditation Assistance for Diagnostic Laboratories

Validation documentation

Validation documentation

Validation documentation

Send us your data and we will analyse the data and compile the report to ISO 15189 requirements. 

Audit/review

Validation documentation

Validation documentation

Review and or audit your processes before and perform gap analysis for  ISO 15189 accreditation. 

Assay validation

Assay validation

Assay validation

 Full assay/instrument implementation;

From planning and testing to full report write up. This is the hassle free product for the entire process enabling you to concrete on your day to day activities. 

Contact us

Assay validation

Assay validation

  With our expert guidance, navigate the complexities of ISO 15189 and IVDR regulations to ensure your diagnostic devise meets the highest standards of quality and compliance. 

Email
  • Regulation updates
  • Terms and Conditions
  • Privacy Policy
  • Modern Slavery Statement

ICS DIAGNOSTIC SOLUTIONS LIMITED

Company Number 16678742

ISOChecks.co.uk

Copyright © 2025 ISOChecks.co.uk - All Rights Reserved.

Powered by